Abstract:
A method for paging a terminal in a multi-carrier system is disclosed in the present invention, and the method includes that: the terminal enters an Idle mode, and the system selects as a paging carrier for the terminal a fully configured carrier which a Multicast Broadcast Service (MBS) is sent on so as to send a paging message; the terminal receives MBS service on the carrier where the MBS service is sent, simultaneously receives the paging message on the paging carrier, and performs the corresponding operation according to the paging message. A system for paging a terminal in a multi-carrier system is also disclosed in the present invention. Based on the method and system, it is possible for the terminal to receive the paging message of the system efficiently and duly while receiving multicast broadcast service.
Abstract:
A method for paging a terminal in a multi-carrier system is disclosed in the present invention, and the method includes that: the terminal enters an Idle mode, and the system selects as a paging carrier for the terminal a fully configured carrier which a Multicast Broadcast Service (MBS) is sent on so as to send a paging message; the terminal receives MBS service on the carrier where the MBS service is sent, simultaneously receives the paging message on the paging carrier, and performs the corresponding operation according to the paging message. A system for paging a terminal in a multi-carrier system is also disclosed in the present invention. Based on the method and system, it is possible for the terminal to receive the paging message of the system efficiently and duly while receiving multicast broadcast service.
Abstract:
The present invention discloses an intravenous cytomegalovirus human immune globulin and a manufacturing method thereof, wherein the technical problem to be solved is to improve the purity, yield, and safety of the product. The intravenous cytomegalovirus human immune globulin of the present invention has a specific activity of no less than 2.5 PEI-U/mg, an anti-CMV titer of no less than 100 PEI-U/ml, a purity of greater than 98.2%, and a protein content of 51˜55 mg/ml. The present invention employs caprylic acid precipitation and anion exchange chromatography for replacing the step of ethanol precipitation in the conventional cold ethanol method to keep IgG in the supernatant and maintain the activity of the IgG; the present invention employing processes of caprylic acid inactivation of virus and nanometer film virus removal can effectively protect the safety of the product, and studies show that the preparing method of the present invention not only improves the purity, yield, and safety of the product; but also saves energy and reduces the cost of production.